Mindfulness Oriented Recovery Enhancement for Chronic Pain and Opioid Relapse
CompletedNot applicableNCT04491968
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The objective of this study is to rigorously examine the impact of online MORE, delivered through video conference, on opioid use and chronic pain among individuals receiving methadone maintenance treatment (MMT). This study is a randomized controlled trial to test the efficacy of online MORE on opioid use and chronic pain immediately after treatment and 8-weeks post-treatment as compared to treatment as usual (TAU) among 154 individuals in MMT. Further, mediators (i.e., metacognitive awareness, negative emotion regulation, and natural reward processing) and moderators (i.e., gender, race, income, mental health, trauma, and MMT phase) of treatment response will be explored.
Study details
- Official title
- Mindfulness Oriented Recovery Enhancement for Chronic Pain and Opioid Relapse as an Adjunct to Methadone Treatment
- Conditions
- Interventions
- Behavioral: Mindfulness Oriented Recovery Enhancement
- Other: Methadone Treatment as Usual
- Sponsor
- Rutgers, The State University of New Jersey
- Collaborators
- University of Utah; National Center for Complementary and Integrative Health (NCCIH)
- Start date
- 2020-08-13
- Primary completion
- 2022-06-08
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * English-speaking * Age ≥18 * Currently on methadone * Experiencing non-malignant pain for a duration of 3 months or longer. Exclusion Criteria: * Severe cognitive impairment or active psychosis * Suicide risk * Inability to attend the MORE group, if randomized to that arm.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04491968